SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-757965
Filing Date
2016-11-03
Accepted
2016-11-03 06:43:26
Documents
56
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d168595d10q.htm 10-Q 583642
2 EX-31.1 d168595dex311.htm EX-31.1 6471
3 EX-31.2 d168595dex312.htm EX-31.2 6495
4 EX-32.1 d168595dex321.htm EX-32.1 3819
11 GRAPHIC g168595new.jpg GRAPHIC 130731
  Complete submission text file 0001193125-16-757965.txt   3142094

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT epzm-20160930.xml EX-101.INS 464668
6 XBRL TAXONOMY EXTENSION SCHEMA epzm-20160930.xsd EX-101.SCH 35780
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epzm-20160930_cal.xml EX-101.CAL 50932
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epzm-20160930_def.xml EX-101.DEF 101305
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE epzm-20160930_lab.xml EX-101.LAB 309142
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epzm-20160930_pre.xml EX-101.PRE 208640
Mailing Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 4TH FLOOR CAMBRIDGE MA 02139 617-229-5872
Epizyme, Inc. (Filer) CIK: 0001571498 (see all company filings)

IRS No.: 261349956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35945 | Film No.: 161970076
SIC: 2834 Pharmaceutical Preparations